Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NUDT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PEX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PNPLA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NUDT22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITSN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAALAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGC16275 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRC75B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDKN2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAM22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETSIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on